Berman Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $56K | Buy |
614
+46
| +8% | +$4.2K | 0.01% | 637 |
|
|
2021
Q2 | $44K | Buy |
568
+371
| +188% | +$28.7K | 0.01% | 633 |
|
|
2021
Q1 | $14K | Buy |
197
+141
| +252% | +$10K | ﹤0.01% | 927 |
|
|
2020
Q4 | $9K | Buy |
56
+11
| +24% | +$1.77K | ﹤0.01% | 965 |
|
|
2020
Q3 | $6K | Sell |
45
-15
| -25% | -$2K | ﹤0.01% | 989 |
|
|
2020
Q2 | $9K | Buy |
60
+45
| +300% | +$6.75K | ﹤0.01% | 810 |
|
|
2020
Q1 | $1K | Sell |
15
-13
| -46% | -$867 | ﹤0.01% | 1365 |
|
|
2019
Q4 | $3K | Buy |
28
+15
| +115% | +$1.61K | ﹤0.01% | 1132 |
|
|
2019
Q3 | $0 | Sell |
13
-82
| -86% | – | ﹤0.01% | 1573 |
|
|
2019
Q2 | $14K | Buy |
95
+64
| +206% | +$9.43K | ﹤0.01% | 625 |
|
|
2019
Q1 | $3K | Buy |
+31
| New | +$3K | ﹤0.01% | 1025 |
|